Abstract
Several risk factors have been reported that may favour the development of chronic rejection. From October 1988 to December 1993, 97 liver transplants with survival of more than 3 months were included in the study. Fifty-two patients (54.1%) had chronic hepatitis C virus (HCV) infection before liver transplantation. Immunosuppression consisted of cyclosporine A and prednisone, whereas 14 patients received FK 506 and prednisone. Severe graft HCV reinfection was present in 32 patients (61.5%) after liver transplantation and chronic graft hepatitis C was found in 26 cases at the end of the study. Chronic rejection occurred in 8 of 97 allografts (8.25%); 5 presented chronic rejection and concomitant chronic graft hepatitis C. The incidence of chronic rejection in patients with HCV infection before liver transplantation (9.6%) did not differ when compared with the negative HCV patients (6.6%). However, when the 26 cases that developed graft dysfunction due to chronic hepatitis C after liver transplantation were considered, 5 presented chronic rejection, a significantly higher incidence than in the remaining patients (3 of 71) (Yates chi-square test: P< 0.05). In our experience, there appears to be a relationship between the development of chronic rejection and chronic hepatitis C in the graft after liver transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hubscher S, Neuberger J (1993) Chron- 5. is rejection of the liver allograft. In: Neuberger J, Adams D (eds) Immunology of liver transplantation. Arnold, London, pp 216–229
Demetris AJ, Murase N, Delaney CP, Woan M, Fung JJ, Starzl TE (1995) The 6. liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc 27: 6770
Poterucha JJ, Raquela J, Lumeng L, Lee C-H, Taswell HF, Wiesner RH (1992) Diagnosis of chronic hepatitis C after liver transplantation by the detection of 7. viral sequences with polymerase chain reaction. Hepatology 15: 42–45
Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzl TE, Van Thiel DH 8. (1992) Incidence, prevalence and clinical course of hepatitis C following liver transplantation. Gastroenterology 103: 323–324
Vargas V, Comas P, Casells LL, Quer J, Esteban JI, Allende E, Esteban R, Guardia J, Margarit C (1994) Incidence and outcome of hepatitis C virus after liver transplantation. Transplant Int 7 (Suppl 1): S216–5220
Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Koleskinov V, Bodenheimer H, Emre S, Miller CM (1995) Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 21: 30–34
Ferrell LD, Wright JR, Roberts J, Ascher N, Lake J (1992) Hepatitis C viral infection in liver transplant recipients. Hepatology 16: 865–876
Bronster O, Mariez R, Kusne S, Irish W, Roland A, Jain A, LlulI R, Demetris AJ, Starzl TE (1995) Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. Transplant Proc 27: 1206–1207
Mariez R, Whitw LT, Linden P, Kusne S, Martin M, Kramer D, Demetris AJ, Van Thiel DH, Starzl TE, Duquesnoy RJ (1993) The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 55: 1067–1071
Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, Okamoto H, Bismuth H, Brechot C (1995) Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108: 1088–1096
Charco R, Ruiz C, Allende E, Balsells J, Lâzaro JL, Murio E, Bilbao I, Gifre E, Margarit C (1995) Experience in therapy of chronic liver allograft rejection. Transplant Proc 27: 2018–2019
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Charco, R. et al. (1996). Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_49
Download citation
DOI: https://doi.org/10.1007/978-3-662-00818-8_49
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61024-3
Online ISBN: 978-3-662-00818-8
eBook Packages: Springer Book Archive